Australia, Philippines, African Union ban AstraZeneca's COVID-19 shot : Bulletin: Business Today
Business Today

Australia, Philippines, African Union ban AstraZeneca's COVID-19 shot

Loading the player...

Rashi Bisaria | April 9, 2021

Australia, Philippines, African Union ban AstraZeneca's COVID-19 shot
Australia and the Philippines limited use of AstraZeneca's COVID-19 vaccine on Thursday, while the African Union dropped plans to buy the shot amid global shortages, dealing further blows to the company's hopes to deliver a vaccine for the world. The vaccine - developed with Oxford University and considered a frontrunner in the global vaccine race - has been plagued by safety concerns and supply problems since Phase III trial results were published in December.
European data suggests 'very small risk' of blood clotting due to Covishield vaccine in India: Gagandeep Kang
India should have reported 320 cases of blood clot associated with administering of Covishield vaccine by now if the European levels of risk calculated for AstraZeneca were to apply to the country, according to eminent scientist Gagandeep Kang who termed it a "very small risk" with absolutely no need for apprehension.

Iran's Chabahar port likely ready by May as India speeds up work: US report
After a brief halt, India accelerated the work on Chabahar Port early this year and the strategic Iranian port is expected to be operational by next month, a Congressional report has said. In 2015, India agreed to help develop Iran's Chabahar Port and an associated railway that would enable India to trade with Afghanistan unimpeded by Pakistan
Will have to prioritise COVID-19 vaccination as per availability: PM Modi
Prime Minister Narendra Modi on Thursday said the country will have to prioritise COVID-19 vaccination as per the availability of vaccines.  The prime minister said the vaccination criteria in India is not different from that in rich countries of the world. He also asked states to make efforts to achieve 100 per cent vaccination in the age group of above 45 years, which is currently eligible for vaccination.
Mukesh Ambani to challenge SEBI's Rs 25 crore fine in SAT
Reliance Industries Ltd (RIL) CMD Mukesh Ambani will challenge in the Securities Appellate Tribunal (SAT) the SEBI order imposing Rs 25 crore fine for violation of takeover regulations. On Wednesday, the Securities and Exchange Board of India had fined Ambani, Anil Ambani, Nita Ambani, Tina Ambani and other individuals and entities for non-compliance with takeover norms in a case dating back to 2000.
RBI announces open market purchase of Rs 25,000 crore govt securities on Apr 15
Following RBI Governor Shaktikanta Das' announcements on Wednesday, the apex bank notified on Thursday that it would conduct open market purchase of government securities of Rs 1 lakh crore under the G-sec Acquisition Programme (G-SAP). The first purchase of the government securities for an aggregate amount of Rs 25,000 crore under G-SAP 1.0 will be conducted on April 15.

More from this section